Medtronic (MDT) Income from Non-Controlling Interests (2016 - 2026)

Medtronic (MDT) reported Income from Non-Controlling Interests of $16.0 million for Q2 2026, up 220.0% on a YoY basis from $5.0 million in Q2 2025, and up 166.67% sequentially from $6.0 million in Q1 2026.

Medtronic (MDT) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends

Medtronic (MDT) has 11 years of Income from Non-Controlling Interests data on file, last reported at $16.0 million in Q2 2026.

  • For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 220.0% year-over-year to $16.0 million; the trailing twelve-month figure through Apr 2026 stood at $36.0 million (up 24.14% YoY), and the FY2026 full-year result was $37.0 million, up 27.59% from the prior year.
  • Income from Non-Controlling Interests rose to $16.0 million in Q2 2026, from $6.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $16.0 million in Q2 2026 to a low of $2.0 million in Q3 2022.
  • A 5-year average of $7.1 million and a median of $6.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
  • Across the five-year window, Income from Non-Controlling Interests slumped 75.0% in 2023 and surged 350.0% in 2024, its largest moves.
  • Tracing MDT's Income from Non-Controlling Interests over 5 years: stood at $8.0 million in 2022, then tumbled by 75.0% to $2.0 million in 2023, then surged by 350.0% to $9.0 million in 2024, then declined by 22.22% to $7.0 million in 2025, then soared by 128.57% to $16.0 million in 2026.
  • Business Quant data shows MDT's Income from Non-Controlling Interests at $16.0 million in Q2 2026, $6.0 million in Q1 2026, and $7.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 181.51 Bn 174.22 Bn 6.27 Bn -
2 Stryker 128.20 Bn 125.32 Bn 3.81 Bn -
3 Medtronic 107.69 Bn 98.47 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 68.05 Bn 66.59 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 47.52 Bn 43.85 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.46 Bn 26.17 Bn 1.98 Bn 22.00 Mn
7 Dexcom 28.25 Bn 27.13 Bn 750.30 Mn -
8 Smith & Nephew 26.73 Bn 26.15 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn -5.85 Mn
10 Steris 21.43 Bn 20.99 Bn 697.10 Mn 100,000.00

Historic Data

Download Data
DateValue
Apr 24, 2026 16.00 Mn
Jan 23, 2026 6.00 Mn
Oct 24, 2025 7.00 Mn
Jul 25, 2025 7.00 Mn
Apr 25, 2025 5.00 Mn
Jan 24, 2025 9.00 Mn
Oct 25, 2024 9.00 Mn
Jul 26, 2024 6.00 Mn
Apr 26, 2024 5.00 Mn
Jan 26, 2024 15.00 Mn
Oct 27, 2023 2.00 Mn
Jul 28, 2023 6.00 Mn
Apr 28, 2023 9.00 Mn
Jan 27, 2023 6.00 Mn
Oct 28, 2022 8.00 Mn
Jul 29, 2022 2.00 Mn
Apr 29, 2022 6.00 Mn
Jan 28, 2022 4.00 Mn
Oct 29, 2021 6.00 Mn
Jul 30, 2021 6.00 Mn